President's Council on Bioethics

Last updated
US-PresidentsCouncilOnBioethics-Logo.svg

The President's Council on Bioethics (PCBE) was a group of individuals appointed by United States President George W. Bush to advise his administration on bioethics. Established on November 28, 2001, by Executive Order 13237, the council was directed to "advise the President on bioethical issues that may emerge as a consequence of advances in biomedical science and technology". [1] It succeeded and largely replaced the National Bioethics Advisory Commission, appointed by President Bill Clinton in 1996, which expired in 2001.

Contents

The members of the council were appointed directly by the President; the President also chose the chairperson of the council (last appointed Chair was Edmund D. Pellegrino). Council members, totaling no more than 18, were appointed for a two-year term, after which time they could be reappointed by the President. Individuals appointed could not be officers or employees of the federal government. Executive Order 13237 was renewed in 2003, 2005 and again in 2007. [2]

Expiration and replacement

In June 2009, President Barack Obama's administration informed members of the council that their services were no longer needed. [3] Through a spokesperson, Obama made clear that he intended to replace the committee with a body that "offers practical policy options" rather than philosophical guidance. [3]

Executive Order 13521 of November 24, 2009, superseded the previous council by establishing the Presidential Commission for the Study of Bioethical Issues. [4] On November 25, 2009, Obama named Amy Gutmann, the president of the University of Pennsylvania, to chair his new advisory panel on bioethics. James W. Wagner, the president of Emory University, was appointed vice chairperson. [5]

Criticism

Critics have questioned the motives and goals of the PCBE. Elizabeth Blackburn, who was dismissed from the Commission, co-authored an article, citing examples published by other members, suggesting that it was set up to justify President Bush's positions on stem cell research and abortion, writing "...our concern is that some of their contents... may have ended up distorting the potential of biomedical research and the motivation of some of its researchers." [6] [7]

Bioethicist Leslie A. Meltzer accused the council of wrapping "political and religious agendas in the guise of dignity," and described them as largely Christian-affiliated neoconservatives; philosophers and political scientists rather than bench scientists. Meltzer said that Council members mischaracterized the positions of their opponents and used invective rather than addressing the merits of the arguments. [8]

The response to President Obama's decision to disband the council drew both criticism and praise. Colleen Carroll Campbell, a former speechwriter for President Bush and a member of the conservative advocacy group Ethics and Public Policy Center predicted that "Obama's desire to see his policies backed by expert 'consensus' more likely will be realized with a new commission composed of like-minded political liberals steeped in utilitarianism than with the brainy, diverse and unpredictable crew that populated the now-defunct council." [9] In contrast, Jacob M. Appel of New York's Mount Sinai Hospital wrote that "the panel itself, far from being an incubator of intellectual ferment, had evolved into a publicly funded right-wing think tank with a handful of token moderates for window dressing" and argued that "Obama was wise to scrap the entire panel and to start over." [10]

Members and staff

Chairmen

Members

Council staff

Reports and publications

See also

Related Research Articles

The National Academy of Medicine (NAM), known as the Institute of Medicine (IoM) until 2015, is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC).

<span class="mw-page-title-main">President's Intelligence Advisory Board</span> American government office

The President's Intelligence Advisory Board (PIAB) is an advisory body to the Executive Office of the President of the United States. According to its self-description, it "provides advice to the President concerning the quality and adequacy of intelligence collection, of analysis and estimates, of counterintelligence, and of other intelligence activities."

<span class="mw-page-title-main">Leon Kass</span> American physician, scientist, and academic

Leon Richard Kass is an American physician, scientist, educator, and public intellectual. Kass is best known as a proponent of liberal arts education via the "Great Books," as a critic of human cloning, life extension, euthanasia and embryo research, and for his tenure as chairman of the President's Council on Bioethics from 2001 to 2005. Although Kass is often referred to as a bioethicist, he eschews the term and refers to himself as "an old-fashioned humanist. A humanist is concerned broadly with all aspects of human life, not just the ethical."

<span class="mw-page-title-main">Elizabeth Blackburn</span> Australian-born American biological researcher

Elizabeth Helen Blackburn, is an Australian-American Nobel laureate who is the former president of the Salk Institute for Biological Studies. In 1984, Blackburn co-discovered telomerase, the enzyme that replenishes the telomere, with Carol W. Greider. For this work, she was awarded the 2009 Nobel Prize in Physiology or Medicine, sharing it with Carol W. Greider and Jack W. Szostak, becoming the first Australian woman Nobel laureate.

<span class="mw-page-title-main">2004 California Proposition 71</span> California law

Proposition 71 of 2004 is a law enacted by California voters to support stem cell research in the state. It was proposed by means of the initiative process and approved in the 2004 state elections on November 2. The Act amended both the Constitution of California and the Health and Safety Code.

The stem cell controversy concerns the ethics of research involving the development and use of human embryos. Most commonly, this controversy focuses on embryonic stem cells. Not all stem cell research involves human embryos. For example, adult stem cells, amniotic stem cells, and induced pluripotent stem cells do not involve creating, using, or destroying human embryos, and thus are minimally, if at all, controversial. Many less controversial sources of acquiring stem cells include using cells from the umbilical cord, breast milk, and bone marrow, which are not pluripotent.

<span class="mw-page-title-main">Edmund Pellegrino</span>

Edmund Daniel Pellegrino was an American bioethicist and academic who served as the 11th president of The Catholic University of America (CUA) from 1978 to 1982. For 35 years, Pellegrino was a distinguished professor of medicine and medical ethics and the Director of the Kennedy Institute of Ethics at Georgetown University. Pellegrino was an expert both in clinical bioethics, and in the field of medicine and the humanities, specifically, the teaching of humanities in medical school, which he helped pioneer). He was the second layman to hold the position of President of Catholic University.

<span class="mw-page-title-main">President's Council of Advisors on Science and Technology</span> White House advisory board

The President's Council of Advisors on Science and Technology (PCAST) is a council, chartered in each administration with a broad mandate to advise the president of the United States on science and technology. The current PCAST was established by Executive Order 13226 on September 30, 2001, by George W. Bush, was re-chartered by Barack Obama's April 21, 2010, Executive Order 13539, by Donald Trump's October 22, 2019, Executive Order 13895, and by Joe Biden's February 1, 2021, Executive Order 14007.

National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research was the first public national body to shape bioethics policy in the United States.

Jonathan D. Moreno is an American philosopher and historian who specializes in the intersection of bioethics, culture, science, and national security, and has published seminal works on the history, sociology and politics of biology and medicine. He is an elected member of the National Academy of Medicine.

The Nuffield Council on Bioethics is a UK-based independent charitable body, which examines and reports on bioethical issues raised by new advances in biological and medical research. Established in 1991, the Council is funded by the Nuffield Foundation, the Medical Research Council and the Wellcome Trust. The Council has been described by the media as a 'leading ethics watchdog', which 'never shrinks from the unthinkable'.

Stem cell laws are the law rules, and policy governance concerning the sources, research, and uses in treatment of stem cells in humans. These laws have been the source of much controversy and vary significantly by country. In the European Union, stem cell research using the human embryo is permitted in Sweden, Spain, Finland, Belgium, Greece, Britain, Denmark and the Netherlands; however, it is illegal in Germany, Austria, Ireland, Italy, and Portugal. The issue has similarly divided the United States, with several states enforcing a complete ban and others giving support. Elsewhere, Japan, India, Iran, Israel, South Korea, China, and Australia are supportive. However, New Zealand, most of Africa, and most of South America are restrictive.

Stem cell laws and policy in the United States have had a complicated legal and political history.

Sheldon Krimsky was a professor of Urban and Environmental Policy and Planning at Tufts University, and adjunct professor in the Department of Family Medicine and Community Health at Tufts University School of Medicine. He was a fellow of the Hastings Center, an independent bioethics research institution.

Human subject research legislation in the United States can be traced to the early 20th century. Human subject research in the United States was mostly unregulated until the 20th century, as it was throughout the world, until the establishment of various governmental and professional regulations and codes of ethics. Notable – and in some cases, notorious – human subject experiments performed in the US include the Tuskegee syphilis experiment, human radiation experiments, the Milgram obedience experiment and Stanford prison experiments and Project MKULTRA. With growing public awareness of such experimentation, and the evolution of professional ethical standards, such research became regulated by various legislation, most notably, those that introduced and then empowered the institutional review boards.

The Presidential Commission for the Study of Bioethical Issues was created by Executive Order 13521 on November 24, 2009. The Bioethics Commission advised President Barack Obama on bioethical issues arising from advances in biomedicine and related areas of science and technology. It replaced The President's Council on Bioethics appointed by United States President George W. Bush to advise his administration on bioethics, and the National Bioethics Advisory Commission (1996-2001). No national organization replaced it when its authorization expired; it "held its final meeting at the end of August 2016 and closed its doors."

Carlo Petrini is an Italian scientist and Director of Researh at the Italian National Institute of Health, where he is head of the Bioethics Unit.

<span class="mw-page-title-main">Francoise Baylis</span> Canadian bioethicist

Françoise Elvina BaylisFISC is a Canadian bioethicist whose work is at the intersection of applied ethics, health policy, and practice. The focus of her research is on issues of women's health and assisted reproductive technologies, but her research and publication record also extend to such topics as research involving humans, gene editing, novel genetic technologies, public health, the role of bioethics consultants, and neuroethics. Baylis' interest in the impact of bioethics on health and public policy as well as her commitment to citizen engagement]and participatory democracy sees her engage with print, radio, television, and other online publications.

Patricia A. King is a professor of law emeritus at Georgetown University Law Center and an adjunct professor in the School of Hygiene and Public Health at Johns Hopkins University. Her expertise lies at the intersection of law, medicine, ethics, and public policy. In 1979, she became the first African-American woman law professor to receive tenure at Georgetown.

References

  1. Executive Order 13237 - Creation of the President's Council on Bioethics, November 28, 2001, Vol. 66, No. 231, 66 FR 59851
  2. Creation of the Council Archived 2005-05-29 at the Wayback Machine , President's Council on Bioethics Website, Retrieved 2009-12-07.
  3. 1 2 Wade, Nicholas. Obama Plans to Replace Bush’s Bioethics Panel. The New York Times June 17, 2009
  4. Executive Order 13521 - Establishing the Presidential Commission for the Study of Bioethical Issues, November 24, 2009, Vol. 74, No. 228, 74 FR 62671
  5. "Obama taps Penn's Gutmann to lead bioethics panel," Philadelphia Inquirer, Nov. 25, 2009
  6. AP (2004-03-19). "Scientists rally around stem cell advocate fired by Bush". USA Today. Retrieved 2008-05-30.
  7. Blackburn E, Rowley J (2004) Reason as Our Guide. PLoS Biol 2(4): e116 doi : 10.1371/journal.pbio.0020116 Free Text
  8. Human Dignity and Bioethics: Essays Commissioned by the President's Council on Bioethics, Book Review by Leslie A. Meltzer, New England Journal of Medicine, 359:660 (August 7, 2008)
  9. Campbell, Colleen Carroll. Dissolution of bioethics council is a loss for America [ permanent dead link ] St. Louis Post Dispatch, July 2, 2009
  10. Moving Bioethics Forward, St. Louis Post-Dispatch, July 8, 2009.